Zhejiang Medicine Co Ltd (600216)

Shanghai
Currency in CNY
15.85
+0.10(+0.63%)
Closed·
600216 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
Unusual trading volume
Fair Value
Day's Range
15.3816.34
52 wk Range
9.4719.40
Key Statistics
Edit
Bid/Ask
15.80 / 15.81
Prev. Close
15.75
Open
15.61
Day's Range
15.38-16.34
52 wk Range
9.47-19.4
Volume
64.49M
Average Volume (3m)
28.43M
1-Year Change
59.44%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600216 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
17.00
Upside
+7.26%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Zhejiang Medicine Co Ltd News & Analysis

No news in this category
Looks like there are no results in this news category

Zhejiang Medicine Co Ltd Company Profile

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company provides injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin products. The company was founded in 1997 and is based in Shaoxing, China.

Employees
5815
Market
China

Compare 600216 to Peers and Sector

Metrics to compare
600216
Peers
Sector
Relationship
P/E Ratio
10.4x27.6x−0.5x
PEG Ratio
0.040.050.00
Price/Book
1.4x2.9x2.6x
Price / LTM Sales
1.6x3.6x3.1x
Upside (Analyst Target)
7.3%6.6%47.0%
Fair Value Upside
Unlock−3.0%−1.8%Unlock

Analyst Ratings

2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 17.00
(+7.26% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.54%
Dividend Yield
0.95%
Industry Median 1.47%
Annualised payout
0.15
Paid annually
5-Years Growth
-18.03%
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.35 / --
Revenue / Forecast
2.26B / --
EPS Revisions
Last 90 days

600216 Income Statement

People Also Watch

25.11
603816
-1.26%
56.74
600132
-1.68%
6.61
002035
-0.45%

FAQ

What Stock Exchange Does Zhejiang Medicine Trade On?

Zhejiang Medicine is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Medicine?

The stock symbol for Zhejiang Medicine is "600216."

What Is the Zhejiang Medicine Market Cap?

As of today, Zhejiang Medicine market cap is 15.24B.

What Is Zhejiang Medicine's Earnings Per Share (TTM)?

The Zhejiang Medicine EPS (TTM) is 1.54.

When Is the Next Zhejiang Medicine Earnings Date?

Zhejiang Medicine will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is 600216 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang Medicine Stock Split?

Zhejiang Medicine has split 4 times.

How Many Employees Does Zhejiang Medicine Have?

Zhejiang Medicine has 5815 employees.

What is the current trading status of Zhejiang Medicine (600216)?

As of 12 Jun 2025, Zhejiang Medicine (600216) is trading at a price of 15.85, with a previous close of 15.75. The stock has fluctuated within a day range of 15.38 to 16.34, while its 52-week range spans from 9.47 to 19.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.